Costs of illness due to endemic cholera

Epidemiology and Infection

Volumn 140, Issue 3, 2012, Pages 500-509

  Poulos, C ^a   Riewpaiboon, A ^b   Stewart, J F ^c   Clemens, J ^d   Guh, S ^c   Agtini, M ^e   Sur, D ^f   Islam, Z ^g   Lucas, M ^h   Whittington, D ^h,i,j,k,l,m  

^a RTI INTERNATIONAL   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d International Vaccine Institute   (South Korea)

^e NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^f NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^g INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^h MINISTRY OF SCIENCE AND TECHNOLOGY   (Mozambique)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j UNIVERSITY OF INDONESIA   (Indonesia)

^k Centre for Environmental Hygiene and Medical Examination   (Mozambique)

^l UNIVERSITY OF WASHINGTON   (United States)

^m NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

more..

Author keywords

Cholera; health economics

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BANGLADESH; CHILD; CHOLERA; COMMUNITY CARE; CONTROLLED STUDY; COST OF ILLNESS; ECONOMIC EVALUATION; ENDEMIC DISEASE; FAMILY; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; INCIDENCE; INCOME; INDIA; INDONESIA; MAJOR CLINICAL STUDY; MOZAMBIQUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHOLERA; COST OF ILLNESS; ENDEMIC DISEASES; FEMALE; HUMANS; INDIA; INDONESIA; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84856295281     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811000513     Document Type: Article

References (28)

1. World Health Organization (WHO). Cholera, 2006. Weekly Epidemiological Record 2007; 82: 273-284.
2. DeRoeck D, et al. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 2005; 23: 2762-2774.
3. Sur D, et al. The burden of cholera in the slums of Kolkata, India: data from a prospective, communitybased study. Archives of Disease in Childhood 2005; 11: 1175-1181. (Pubitemid 41565281)
4. Agtini MR, et al. Shigellosis and cholera in Jakarta: epidemiologic, clinical and microbiologic features of diarrhea cases detected in population-based surveillance. BMC Infectious Diseases 2005; 5: 89.
5. Stewart JF. Interim report on treatment costs. DOMI Report, 2005.
6. Cropper M, et al. The value of preventing malaria in Tigray, Ethiopia. Report to the World Health Organization, 1999.
7. Asenso-Okyere WK, Dzator JA. Household cost of seeking malaria care. A retrospective study of two districts in Ghana. Social Science and Medicine 1997; 45: 659-667. (Pubitemid 27290495)
8. Chima RI, et al. The economic impact of malaria in Africa : a critical review of the evidence. Health Policy 2003; 63: 17-36. (Pubitemid 35418232)
9. Riewpaiboon A. Cholera treatment cost at the Infectious Disease Hospital, Kolkata, India. Report to IVI, 2007, June.
10. Riewpaiboon A, Islam Z. Institutional cost of treatment of cholera in Bangladesh. Report to IVI, 2007, October.
11. Riewpaiboon A. Treatment costs of cholera in Beira, Mozambique. Report to IVI, 2007, June.
12. Poulos C, et al. A cost-benefit analysis of typhoid fever immunization programs in an Indian urban slum community. Journal of Health, Population, and Nutrition 2004; 22: 311-321. (Pubitemid 39585865)
13. Cookson ST, et al. A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population. International Journal of Epidemiology 2007; 26: 212-219.
14. Pan-American Health Organization (PAHO). The economic impact of the cholera epidemic, Peru, 1991. Epidemiological Bulletin 1992; 13: 9-11.
15. Suá rez R, Bradford B. The economic impact of the cholera epidemic in Peru: an application of the cost-ofillness methodology. Water and Sanitation for Health Project, Field Report 415, 1993.
16. Lerman SJ, Shepard DS, Cash RA. Treatment for diarrhoea in Indonesian children : what it costs and who pays for it. Lancet 1985; 326: 651-654. (Pubitemid 15239345)
17. Forsberg BC, et al. Cost of diarrhoeal diseases and the savings from a control programme in Cebu, Philippines. Bulletin of the World Health Organization 1993; 171: 579-586. (Pubitemid 23339748)
18. Bahl R, et al. Costs-of-illness of typhoid fever in Indian urban slum community: implications for vaccination policy. Journal of Health, Population, and Nutrition 2004; 22: 304-310. (Pubitemid 39585864)
19. Poulos C, et al. Cost of illness due to typhoid fever in study sites in five Asian countries. Tropical Medicine and International Health 2011; 16: 314-323.
20. Lorgelly PK, et al. Infantile gastroenteritis in the community: a cost-of-illness study. Epidemiology and Infection 2008; 136: 34-43.
21. Su TT, Kouyaté B, Fless S. Catastrophic household expenditure for health care in a low-income society : a study from Nouna District, Burkina Faso. Bulletin of the World Health Organization 2006; 84: 21-27. (Pubitemid 43150857)
22. Xu K, et al. Household catastrophic health expenditure : a multicountry analysis. Lancet 2003; 362: 111-117. (Pubitemid 36831020)
23. Kim D, et al. Private demand for cholera vaccines in Hue, Vietnam. Value in Health 2008; 11: 119-128. (Pubitemid 351160882)
24. Lucas M, et al. Effectiveness of a mass oral cholera vaccination in Beira, Mozambique. New England Journal of Medicine 2005; 352: 757-767. (Pubitemid 40271170)
25. Islam Z, et al. Private demand for cholera vaccines in rural Bangladesh. Health Policy 2008; 85: 185-195.
26. Whittington D, et al. Private demand for cholera and typhoid vaccines in Kolkata, India. World Development 2009; 37: 399-409.
27. Cahn D, et al. Household demand for typhoid fever vaccines in Hue, Vietnam: implications for immunization programs. Health Policy and Planning 2006; 21: 241-255.
28. Cook J, et al. The reliability of stated preferences for cholera and typhoid vaccines with time to think in Hue, Vietnam. Economic Inquiry 2007; 45: 100-114.